Overview
We are a biotech company working to move autoimmune care from a lifetime of management toward lasting remission for millions of patients, by resetting the immune system at its root. Our proprietary STARx and T Deplete platforms aim to achieve this by combining our AI discovery platform with technology engineered to directly target and eliminate disease-causing Th17 cells in a single step....See more
Website
https://ai3.bio/Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Watertown, MA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$48.0M • Series A
Announced on 9/29/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.